Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | TGM2 | P21980 | 3/20 | 0.38 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | FOXO1 | Q12778 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27749503 | 0.98 | ZDHHC20 (0.49) | ZDHHC20ZDHHC2KDM4EALDH1A1HTT | |
| SCHEMBL1000862 | 0.91 | ZDHHC20 (0.45) | ZDHHC20ZDHHC2KDM4EALDH1A1HTT | |
| Sulfuric Acid SCHEMBL31541484 | 0.91 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2KDM4EALDH1A1HTT | |
| Sulfuric Acid SCHEMBL127061 | 0.91 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2KDM4EALDH1A1HTT | |
| Chloromethane SCHEMBL2594603 | 0.88 | ZDHHC20 (0.42) | ZDHHC20ZDHHC2KDM4EALDH1A1HTT | |
| SCHEMBL28528945 | 0.88 | ZDHHC20 (0.57) | ZDHHC20ZDHHC2KDM4EALDH1A1HTT | |
| SCHEMBL21611 | 0.87 | ZDHHC20 (0.58) | ZDHHC20ZDHHC2KDM4EALDH1A1HTT | |
| SCHEMBL27790589 | 0.87 | ZDHHC20 (0.58) | ZDHHC20ZDHHC2KDM4EALDH1A1HTT | |
| SCHEMBL112125 | 0.85 | ZDHHC20 (0.61) | ZDHHC20ZDHHC2KDM4EALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL131505 | 0.85 | ZDHHC20 (0.56) | ZDHHC20ZDHHC2KDM4EALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 696 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070397-A | Use of fast reverse cationic emulsion polymers with polyvinylamines as retention and drainage aids | 凯米拉公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4739418-A2 | ONE-PASS DEOXYGENATION METHOD FOR POLYACRYLAMIDE PRODUCTION | KEMIRA OYJ (FI) | 2026-05-13 | — | — | EP | claimed |
| EP-4728136-A1 | STRENGTH SYNERGY BETWEEN POLYMER AND PAPERMAKING STRENGTH AID | Ecolab USA, Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4716777-A2 | USE OF AMPHOTERIC EMULSION POLYMERS WITH STRENGTH RESINS AS RETENTION AND DRAINAGE AIDS | KEMIRA OYJ (FI) | 2026-04-01 | — | — | EP | claimed |
| US-12553188-B2 | GPAM compositions and methods | KEMIRA OYJ (FI) | 2026-02-17 | — | — | US | claimed |
| EP-4683950-A1 | DUAL EMULSIFICATION OF ALKENYL SUCCINIC ANHYDRIDE TO IMPROVE SIZING PERFORMANCE AND STABILITY | KEMIRA OYJ (FI) | 2026-01-28 | — | — | EP | claimed |
| US-20250215649-A1 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYSACCHARIDE PROMOTER | KEMIRA OYJ (FI) | 2025-07-03 | — | — | US | claimed |
| CN-115516031-B | GPAM compositions and methods | 凯米拉公司 | 2025-06-17 | — | — | CN | claimed |
| US-20250137200-A1 | HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYMERIC PROMOTER | KEMIRA OYJ (FI) | 2025-05-01 | — | — | US | claimed |
| EP-4256009-B1 | OIL-IN-WATER EMULSIONS | QUADRISE INT LTD (GB) | 2025-04-09 | — | — | EP | claimed |
| EP-1282732-A4 | FLUORESCENT MONOMERS AND TAGGED TREATMENT POLYMERS CONTAINING SAME FOR USE IN INDUSTRIAL WATER SYSTEMS | ONDEO NALCO CO (US) | 2004-12-22 | — | — | EP | claimed |
| US-20040135125-A1 | Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems | ECOLAB USA INC. | 2004-07-15 | — | — | US | claimed |
| US-20040135124-A1 | Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems | ECOLAB USA INC. | 2004-07-15 | — | — | US | claimed |
| US-6753388-B1 | WATER-SOLUBLE, CROSSLINKED POLYMERS COMPRISING (CO)MONOMERS OF (METH)ACRYLAMIDE, (METH)ACRYLIC ACID, SODIUM (METH)ACRYLATE, AMMONIUM (METH)ACRYLATE, 2-ACRYLAMIDO-2-METHYLPROPANESULFONIC ACID, AND/OR DIALKYLAMINOALKYL (METH)ACRYLATE OR SALTS | NALCO COMPANY | 2004-06-22 | — | — | US | claimed |
| WO-2004050791-A1 | DRILLING FLUID AND METHODS OF USE THEREOF | GENESIS INTERNATIONAL OILFIELD SERVICES INC. (CA) | 2004-06-17 | — | — | WO | claimed |
| WO-2004043412-A1 | WATER SOLUBLE MONOMERS AND POLYMERS FOR PROTECTING SUBTRATES FROM ULTRAVIOLET LIGHT | NALCO COMPANY (US) | 2004-05-27 | — | — | WO | claimed |
| US-6645428-B1 | Fluorescent monomers and tagged treatment polymers containing same for use in industrial water systems | ONDEO NALCO COMPANY | 2003-11-11 | — | — | US | claimed |
| EP-1282732-A1 | FLUORESCENT MONOMERS AND TAGGED TREATMENT POLYMERS CONTAINING SAME FOR USE IN INDUSTRIAL WATER SYSTEMS | Ondeo Nalco Company (US) | 2003-02-12 | — | — | EP | claimed |
| US-6344531-B1 | Fluorescent water-soluble polymers | NALCO CHEMICAL COMPANY | 2002-02-05 | — | — | US | claimed |
| WO-2001081654-A1 | FLUORESCENT MONOMERS AND TAGGED TREATMENT POLYMERS CONTAINING SAME FOR USE IN INDUSTRIAL WATER SYSTEMS | ONDEO NALCO COMPANY (US) | 2001-11-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12553188-B2 | GPAM compositions and methods | PGM2, SLC6A9, GNMT | ZDHHC20 4024/4885ZDHHC2 3879/4885KDM4E 2779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.